Mark P. Smith

A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia

Ian M. Morison, Elisabeth M. Cramer, Emma J. Cheesman et al. · Nature Genetics · 2008 · 179 citations

Life Sciences, Genetics, Molecular Biology +12

Clinical evaluation of moroctocog alfa (AF‐CC), a new generation of B‐domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full‐length recombinant factor VIII

Michael Recht, László Nemes, Michał Matysiak et al. · Haemophilia · 2009 · 93 citations

Medicine, Pharmacokinetics, Pharmacology +17

Tinzaparin sodium for thrombosis treatment and prevention during pregnancy

Mark P. Smith, Lucy Norris, Philip Steer et al. · American Journal of Obstetrics and Gynecology · 2004 · 89 citations

Medicine, Obstetrics, Pharmacotherapy +13

A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation

Christopher A. Ludlam, Mark P. Smith, Massimo Morfini et al. · British Journal of Haematology · 2003 · 86 citations

Medicine, Orthopaedic Surgery, Surgery +17

Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII

Christopher A. Ludlam, Peter W. Collins, C. R. M. Hay et al. · Thrombosis and Haemostasis · 2001 · 78 citations

Medicine, Hematology, Surgery +17